Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

NCT00103246

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

NCT00005639

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma

NCT01401530

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Nagoya, Aichi-ken, Japan

Kashiwa, Chiba, Japan

Isehara, Kanagawa, Japan

Chuo-ku, Tokyo, Japan

View Trial Details

Completed

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

NCT00038025

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Cutaneous T-Cell Lymphoma, +22 more
Locations: M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PUVA Maintenance Therapy in Mycosis Fungoides

NCT01686594

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Medical University of Graz Graz, Austria

Department of Dermatology, Medical University of Innsbruck Innsbruck, Austria

Department of Dermatology, General Hospital of the City of Linz Linz, Austria

Department of Dermatology, Hospital Salzburg - Paracelsus Private Medical University Salzburg, Austria

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

NCT00453206

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +67 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

NCT01686165

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions